BlockBeats 消息，12 月 30 日，据 ai_9684xtpa 分析称，BIO Protocol 已通过筹款获得 3,020 万美元资金：私募共两轮，共融资 230 万美元，估值分别为 3500 万美元 和 6900 万美元；公募共三轮（即 BIO Genesis 拍卖），共融资 2,790 万美元，三轮估值分别为 8500 万美元 / 1.42 亿美元 / 2.19 亿美元。
目前 BIO 已上线 Bybit 和 Bitget 盘前交易，以 12.29 22:00 两大平台的盘前均价 $0.9659 计算，BIO FDV 约为 32 亿美元。私募投资人：占总供应量 13.60%；公募投资人：占总供应量 20.00%。成本如下：
私募· 种子轮前：成本约 0.01054 美元，当前浮盈 91.62 倍；· 种子轮中：成本约 0.02078 美元，当前浮盈 46.48 倍；公募· Round 1：成本约 0.0256 美元，当前浮盈 37.73 倍；· Round 2：成本约 0.04277 美元，当前浮盈 22.58 倍；· Round 3：成本约 0.06596 美元，当前浮盈 14.64 倍。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.